vs
Cambium Networks Corp（CMBM）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Cambium Networks Corp的1.9倍（$75.5M vs $40.3M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -23.2%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-10.8M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -27.2%）
坎布里姆网络公司是美国的无线通信设备制造商，主营企业WiFi、网络交换设备、物联网相关产品，以及面向企业的固定无线宽带、WiFi接入产品。该公司于2011年10月从摩托罗拉分拆，目前在纳斯达克上市。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
CMBM vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.9倍
$40.3M
营收增速更快
PBYI
高出50.9%
-23.2%
自由现金流更多
PBYI
多$25.2M
$-10.8M
两年增速更快
PBYI
近两年复合增速
-27.2%
损益表 — Q4 FY2024 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $40.3M | $75.5M |
| 净利润 | $-7.2M | — |
| 毛利率 | 36.6% | 69.3% |
| 营业利润率 | -28.4% | 22.7% |
| 净利率 | -17.9% | — |
| 营收同比 | -23.2% | 27.7% |
| 净利润同比 | 71.0% | — |
| 每股收益（稀释后） | $-0.26 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CMBMPBYI
| Q4 25 | — | $75.5M | ||
| Q3 25 | — | $54.5M | ||
| Q2 25 | — | $52.4M | ||
| Q1 25 | — | $46.0M | ||
| Q4 24 | $40.3M | $59.1M | ||
| Q3 24 | $44.7M | $80.5M | ||
| Q2 24 | $45.2M | $47.1M | ||
| Q1 24 | $47.1M | $43.8M |
净利润CMBMPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | $8.8M | ||
| Q2 25 | — | $5.9M | ||
| Q1 25 | — | $3.0M | ||
| Q4 24 | $-7.2M | — | ||
| Q3 24 | $-34.5M | $20.3M | ||
| Q2 24 | $-14.2M | $-4.5M | ||
| Q1 24 | $-18.4M | $-4.8M |
毛利率CMBMPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | 36.6% | 76.4% | ||
| Q3 24 | 43.6% | 63.9% | ||
| Q2 24 | 32.5% | 77.4% | ||
| Q1 24 | 29.8% | 75.5% |
营业利润率CMBMPBYI
| Q4 25 | — | 22.7% | ||
| Q3 25 | — | 17.6% | ||
| Q2 25 | — | 12.7% | ||
| Q1 25 | — | 8.7% | ||
| Q4 24 | -28.4% | 22.6% | ||
| Q3 24 | -69.6% | 27.4% | ||
| Q2 24 | -27.2% | -4.6% | ||
| Q1 24 | -33.1% | -5.3% |
净利率CMBMPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 16.2% | ||
| Q2 25 | — | 11.2% | ||
| Q1 25 | — | 6.5% | ||
| Q4 24 | -17.9% | — | ||
| Q3 24 | -77.3% | 25.2% | ||
| Q2 24 | -31.5% | -9.6% | ||
| Q1 24 | -39.2% | -11.0% |
每股收益（稀释后）CMBMPBYI
| Q4 25 | — | $0.26 | ||
| Q3 25 | — | $0.17 | ||
| Q2 25 | — | $0.12 | ||
| Q1 25 | — | $0.06 | ||
| Q4 24 | $-0.26 | $0.40 | ||
| Q3 24 | $-1.22 | $0.41 | ||
| Q2 24 | $-0.51 | $-0.09 | ||
| Q1 24 | $-0.66 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | $67.6M | $22.7M |
| 股东权益账面价值 | $-3.2M | $130.3M |
| 总资产 | $173.7M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资CMBMPBYI
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
总债务CMBMPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | $67.6M | $68.0M | ||
| Q3 24 | $67.6M | $79.3M | ||
| Q2 24 | $68.9M | $90.7M | ||
| Q1 24 | $63.8M | $102.0M |
股东权益CMBMPBYI
| Q4 25 | — | $130.3M | ||
| Q3 25 | — | $115.3M | ||
| Q2 25 | — | $104.7M | ||
| Q1 25 | — | $97.1M | ||
| Q4 24 | $-3.2M | $92.1M | ||
| Q3 24 | $1.9M | $71.1M | ||
| Q2 24 | $34.1M | $48.5M | ||
| Q1 24 | $45.0M | $51.0M |
总资产CMBMPBYI
| Q4 25 | — | $216.3M | ||
| Q3 25 | — | $202.9M | ||
| Q2 25 | — | $194.9M | ||
| Q1 25 | — | $196.2M | ||
| Q4 24 | $173.7M | $213.3M | ||
| Q3 24 | $194.3M | $220.7M | ||
| Q2 24 | $221.1M | $205.0M | ||
| Q1 24 | $219.8M | $214.1M |
负债/权益比CMBMPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | 36.12× | 1.12× | ||
| Q2 24 | 2.02× | 1.87× | ||
| Q1 24 | 1.42× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-10.4M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-10.8M | $14.4M |
| 自由现金流率自由现金流/营收 | -26.8% | 19.1% |
| 资本支出强度资本支出/营收 | 1.1% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-21.4M | $41.7M |
8季度趋势，按日历期对齐
经营现金流CMBMPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | $-10.4M | $15.6M | ||
| Q3 24 | $8.9M | $11.0M | ||
| Q2 24 | $2.4M | $1.0M | ||
| Q1 24 | $-15.9M | $11.2M |
自由现金流CMBMPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | $-10.8M | $15.6M | ||
| Q3 24 | $6.8M | $11.0M | ||
| Q2 24 | $87.0K | $1.0M | ||
| Q1 24 | $-17.4M | — |
自由现金流率CMBMPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | -26.8% | 26.4% | ||
| Q3 24 | 15.2% | 13.7% | ||
| Q2 24 | 0.2% | 2.1% | ||
| Q1 24 | -37.0% | — |
资本支出强度CMBMPBYI
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | 1.1% | 0.0% | ||
| Q3 24 | 4.8% | 0.0% | ||
| Q2 24 | 5.1% | 0.0% | ||
| Q1 24 | 3.3% | 0.0% |
现金转化率CMBMPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CMBM
| Enterprise | $16.6M | 41% |
| Point To Multi Point | $16.4M | 41% |
| Other | $5.8M | 14% |
PBYI
暂无分部数据
